Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medacta Group SA (0A05) Share Price & Analysis

2 Followers

0A05 Stock Chart & Stats

CHF 108.88-CHF 1.92(-1.74%)
At close: 4:30 PM GMT
CHF110CHF120CHF130Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
CHF 108.60 - CHF 111.60
52-Week Range
CHF 104.60 - CHF 176.60
Previous Close
CHF 110.80
Volume
N/A
Average Volume (3M)
3,903
Market Cap
CHF 2.19B
Enterprise Value
CHF 2.98B
Total Cash (Recent Filing)
CHF 36.10M
Total Debt (Recent Filing)
CHF 321.58M
Price to Earnings (P/E)
30.6
Beta
1.00
Next Earnings
Mar 12, 2027 (Est.)
EPS Estimate
2.45
Last Dividend Ex-Date
May 07, 2026
Dividend Yield
0.99%

Bulls Say, Bears Say

Bulls Say

Sustained Revenue Growth And Profitability

Medacta has more than doubled revenue since 2020 while retaining strong gross, EBITDA, and net margins. This combination indicates meaningful scale, established demand, and the ability to convert growth into profitability, supporting durable earnings potential over the next several quarters.

Above-market Portfolio And Product Momentum

Growth across every major portfolio category, including products expanding faster than their markets, supports Medacta's competitive position. Continued adoption of differentiated knee, hip, extremity, and enabling technologies can broaden procedure relevance and sustain share gains over time.

Sound Balance Sheet With Moderate Leverage

A growing equity base, strong 2025 return on equity, and lower debt-to-equity than in 2020 provide financial resilience. Although debt has risen alongside expansion, moderate leverage should preserve flexibility to fund capacity, innovation, and geographic growth.

Bears Say

Margin Pressure From Mix, FX, And Pricing

The decline in gross margin shows that growth is currently accompanied by pressure from currency, pricing, and business mix. If these factors persist, they could limit operating leverage and make the company's EBITDA improvement targets more dependent on cost control.

Uneven Free-cash-flow Conversion

Cash generation has been less consistent than accounting earnings, with negative first-half free cash flow and prior periods of very low or negative annual free cash flow. Continued inventory investment and capacity spending could constrain internally funded expansion.

U.S. Customer Attrition And Slower Market Growth

The U.S. is strategically important, yet slower market growth and customer attrition are limiting near-term momentum in a key region. Persistent volume migration or customer losses could weaken utilization of Medacta's systems and make regional growth targets harder to achieve.

Medacta Group SA News

0A05 FAQ

What was Medacta Group SA’s price range in the past 12 months?
Medacta Group SA lowest share price was CHF104.60 and its highest was CHF176.60 in the past 12 months.
What is Medacta Group SA’s market cap?
Medacta Group SA’s market cap is CHF2.19B.
When is Medacta Group SA’s upcoming earnings report date?
Medacta Group SA’s next earnings report is estimated for Mar 12, 2027 (not yet confirmed), which is in 119 days.
How were Medacta Group SA’s earnings last quarter?
Medacta Group SA released its earnings results on Sep 09, 2026. The company reported CHF1.94 earnings per share for the quarter.
Is Medacta Group SA overvalued?
According to Wall Street analysts Medacta Group SA’s price is currently Undervalued.
Does Medacta Group SA pay dividends?
Medacta Group SA pays an annual dividend of CHF1.1 which represents an annual dividend yield of 0.99%. See more information on Medacta Group SA dividends here
What is Medacta Group SA’s EPS estimate?
Medacta Group SA’s EPS estimate is 2.45.
How many shares outstanding does Medacta Group SA have?
Medacta Group SA has 20,000,000 shares outstanding.
What happened to Medacta Group SA’s price movement after its last earnings report?
Medacta Group SA reported an EPS of CHF1.94 in its last earnings report. Following the earnings report the stock price went down -5.6%.
Which hedge fund is a major shareholder of Medacta Group SA?
Currently, no hedge funds are holding shares in GB:0A05
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology